Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 156 publications
Correction: Gastrointestinal stromal tumors with the use of ripretinib and sunitinib: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS).
Journal: Frontiers in pharmacology
Published: August 20, 2025
Present management of gastrointestinal stromal tumors.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: August 05, 2025
Cerebral Metastasis of a Gastrointestinal Stromal Tumor: A Case Report and Literature Review.
Journal: Cureus
Published: June 12, 2025
Design, synthesis and biological evaluation of novel platelet-derived growth factor receptor-α (PDGFR-α) inhibitors based on 4-anilinoquinoline and 4-anilinoquinazoline scaffolds.
Journal: European journal of medicinal chemistry
Published: June 09, 2025
New treatments for systemic mastocytosis in 2025.
Journal: Current opinion in allergy and clinical immunology
Published: June 05, 2025
Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 23, 2025
A case report of advanced small intestinal stromal tumor with KIT gene mutation and BRCA2 deletion after multi-line treatments.
Journal: Frontiers in oncology
Published: May 20, 2025
Metabolite identification of ripretinib by UPLC-ESI-MS/MS: in silico prediction, in vitro metabolism, and stability assessment.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: May 19, 2025
Gastrointestinal Stromal Tumor: Current Approaches and Future Directions in the Treatment of Advanced Disease.
Journal: Hematology/oncology clinics of North America
Published: May 14, 2025
Development and Validation of a LC-MS/MS Method for Ripretinib and Its Metabolite: Example of a Journey From Laboratory Bench to Routine Application With a Greenness Assessment.
Journal: Biomedical chromatography : BMC
Published: May 06, 2025
Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor After Imatinib Resistance.
Journal: Pharmaceutics
Published: April 28, 2025
Last Updated: 10/31/2025